<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Multi-Jurisdiction-Regulatory-Consulting on Bioecon</title><link>https://en.bioecon.ru/technologies/multi-jurisdiction-regulatory-consulting/</link><description>Recent content in Multi-Jurisdiction-Regulatory-Consulting on Bioecon</description><generator>Hugo</generator><language>en-US</language><lastBuildDate>Tue, 18 Aug 2026 22:19:08 +0700</lastBuildDate><atom:link href="https://en.bioecon.ru/technologies/multi-jurisdiction-regulatory-consulting/index.xml" rel="self" type="application/rss+xml"/><item><title>Multi-jurisdictional bio-compliance (FDA+EMA+NMPA+PMDA)</title><link>https://en.bioecon.ru/technology/multi-jurisdictional-bio-compliance/</link><pubDate>Sun, 16 Aug 2026 05:34:12 +0000</pubDate><guid>https://en.bioecon.ru/technology/multi-jurisdictional-bio-compliance/</guid><description>Regulatory-affairs consultancies and eCTD submission software that manage biopharmaceutical filings across the FDA, EMA, China&amp;rsquo;s NMPA and Japan&amp;rsquo;s PMDA simultaneously — helping a biologics or biotech developer sequence and harmonize approvals across the world&amp;rsquo;s major drug-regulatory jurisdictions.</description></item></channel></rss>